Switching statin-treated patients from fenofibrate to the prescription omega-3 therapy icosapent ethyl: a retrospective case series

INTRODUCTION: Patients receiving statin therapy for dyslipidaemia often require treatment with an additional agent to control triglyceride levels. Options for add-on therapy include fibrates and omega-3 fatty acids. This case series describes the effects of switching add-on therapy from fenofibrate...

Descripción completa

Detalles Bibliográficos
Autor principal: Castaldo, Richard S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801984/
https://www.ncbi.nlm.nih.gov/pubmed/27065746
http://dx.doi.org/10.1007/s40267-016-0288-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801984/
https://www.ncbi.nlm.nih.gov/pubmed/27065746
http://dx.doi.org/10.1007/s40267-016-0288-3

Ejemplares similares